Rodríguez-Roche R, López ML, Álvarez VM, Morier DL, Guzmán TMG

Language: Spanish
References: 19
Page:
PDF size: 103.16 Kb.

ABSTRACT

Introduction: during dengue epidemics in Cuba, an increase in clinical severity with the epidemics progression in time, particularly in secondary infections, have been frequently observed. It is considered that this increase could be related with genetic changes in the circulating virus.
Objective: to study some biological attributes related to strains isolated at different points of time during the dengue epidemic occurred in Havana city, 2001-2002.
Methods: nine DENV-3 strains were studied. Cytopathogenic effect, viral growth in C6/36 HT and Vero cell lines, viral plaque sizes, temperature sensitivity, neurovirulence in newborn mice and pH influence in the binding of the virus and the cell as well as in the multiplication medium were evaluated.
Results: DENV-3 strains were more cytopathogenic in Vero Cells. However, higher titres were obtained in C6/36 HT cells. All the strains showed reduction of viral titres and plaque size with temperature increasing and low neurovirulence. Basic pH favoured virus-cell binding whereas acid pH was only permissive for some strains isolated at the end of the epidemic. On the other hand, at pH 6.5-7, the viral multiplication medium favoured the growth of strains isolated at the beginning of the epidemic whereas the growth of those isolated at the endof the epidemic was noticeable at pH 7-8.
Conclusions: this study proved the phenotypical changes among strains isolated at different points of time in the epidemic. They might be related to differences in viral fitness or in virulent potential. Nevertheless, some of the studied biological properties suggest that dengue virus-3 strains are less virulent than the Cuban dengue virus 2 strains isolated in 1997.

REFERENCES

1. Halstead SB. Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica. 2006;20(6):407-15.

2. Guzmán MG. Dengue type 3 infection-Nicaragua and Panama October-November, 1994. MMWR. 1995;44:21-4.

3. Guzmán MG, Rosario D, Mune M, Álvarez M, Rodríguez R, Kourí G. Genetic relatedness of the dengue 3 virus isolated in the outbreak of dengue hemorrhagic fever in Nicaragua, 1994. Rev Cubana Med Trop. 1996;48(2):114-7.

4. Guzmán MG, Vázquez S, Martínez E, Álvarez M, Rodríguez R, Kourí G, et al. Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas. Bol Oficina Sanit Panam. 1996;121(2):102-10.

5. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis. 2003;9(7):800-9.

6. Uzcategui NY, Comach G, Camacho D, Salcedo M, Cabello de Quintana M, Jiménez M, et al. Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol. 2003;84(Pt 6):1569-75.

7. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol. 1994;75( Pt 1):65-75.

8. Rodríguez-Roche R, Álvarez M, Holmes EC, Bernardo L, Kourí G, Gould EA, et al. Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis. 2005;11(5):773-4.

9. Kourí G, Guzmán MG, Valdes L, Carbonel I, del Rosario D, Vázquez S, et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis. 1998;4(1):89-92.

10. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis. 2002;2(1):33-42.

11. Pelaez O, Guzmán MG, Kourí G, Perez R, San Martin JL, Vázquez S, et al. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis. 2004;10(4):719-22.

12. Guzmán MG, Kourí G, Valdes L, Bravo J, Vázquez S, Halstead SB. Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks. Rev Panam Salud Publica. 2002;11(4):223-7.

13. Guzmán MG, Kourí G, Halstead SB. Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet. 2000;355(9218):1902-3.

14. Álvarez M, Rodríguez-Roche R, Bernardo L, Morier L, Guzmán G. Improved Dengue virus plaque formation on BHK21 and LLCMK2 cells: Evaluation of some factors. Dengue Bulletin; 2005. p. 29.

15. Bielefeldt-Ohmann H, Meyer M, Fitzpatrick DR, Mackenzie JS. Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res. 2001;73(1):81-9.

16. Rodríguez-Roche R, López Matilla L, Álvarez Vera M, Morier Diaz L, Guzmán Tirado MG. Propiedades biológicas de cepas de virus dengue serotipo 2 aisladas durante la epidemia en Santiago de Cuba, 1997. Rev Cubana Med Trop. 2011;63(3):211-9.

17. Rodríguez-Roche R, Sanchez L, Burgher Y, Rosario D, Álvarez M, Kourí G, et al. Virus Role During Intraepidemic Increase in Dengue Disease Severity. Vector Borne Zoonotic Dis. 2011;11(7):675-81.

18. Rodríguez-Roche R, Álvarez M, Gritsun T, Halstead S, Kourí G, Gould EA, et al. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology. 2005;334(2):154-9.

19. Rodríguez-Roche R, Álvarez M, Gritsun T, Rosario D, Halstead S, Kourí G, et al. Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic. Arch Virol. 2005;150(3):415-25.